Evaluation of Cardiac Markers in Children Undergoing Hematopoietic Stem Cell Transplantation

Gulfer Ozturk1, Betul Tavil2, Meltem Ozguner3

  • 1Department of Biochemistry Diskapi Yildirim Beyazit Education and Research Hospital.

Insights

Hematopoietic stem cell transplantation (HSCT) can cause cardiotoxicity. Heart-type fatty acid binding protein (H-FABP) and high-sensitivity C-reactive protein (hsCRP) show promise in monitoring cardiac health during HSCT.

Area of Science:

  • Cardiology
  • Hematology
  • Oncology

Background:

  • Hematopoietic stem cell transplantation (HSCT) is associated with life-threatening cardiotoxicity and cardiac death.
  • Early detection of cardiac damage is crucial for managing HSCT patients.

Purpose of the Study:

  • To evaluate cardiotoxicity following conventional chemotherapy and HSCT.
  • To assess the efficacy of specific cardiac biomarkers in detecting HSCT-related cardiac events.

Main Methods:

  • A cohort of 20 pediatric patients undergoing HSCT for various diseases was studied.
  • Cardiac biomarkers including H-FABP, GPBB, hsCRP, cTnI, CK-MB mass, and myoglobin were measured on days 0, 7, and 21 post-HSCT.
  • Echocardiography was performed before and one month after HSCT.

Main Results:

  • Serum H-FABP levels were significantly elevated by day 21 post-HSCT (P < 0.05).
  • hsCRP levels peaked on day 7 and were significantly higher than on days 0 and 21 (P < 0.05).
  • GPBB levels decreased significantly by day 7 (P < 0.05), while myoglobin, cTnI, and CK-MB mass remained within normal ranges.

Conclusions:

  • H-FABP and hsCRP emerge as sensitive indicators for monitoring cardiotoxicity during HSCT.
  • These markers may offer superior detection capabilities compared to GPBB, cTnI, CK-MB mass, and myoglobin in this context.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
751